Correlation Between Processa Pharmaceuticals and ACRO Biomedical

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and ACRO Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and ACRO Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and ACRO Biomedical Co, you can compare the effects of market volatilities on Processa Pharmaceuticals and ACRO Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of ACRO Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and ACRO Biomedical.

Diversification Opportunities for Processa Pharmaceuticals and ACRO Biomedical

0.63

Correlation Coefficient

Processa Pharmaceuticals  ACRO Biomedical

Poor diversification

The 3 months correlation between Processa and ACRO is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and ACRO Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACRO Biomedical and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with ACRO Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACRO Biomedical has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and ACRO Biomedical go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and ACRO Biomedical

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 2.32 times more return on investment than ACRO Biomedical. However, Processa Pharmaceuticals is 2.32 times more volatile than ACRO Biomedical Co. It trades about 0.02 of its potential returns per unit of risk. ACRO Biomedical Co is currently generating about -0.13 per unit of risk. If you would invest  25.00  in Processa Pharmaceuticals on May 15, 2025 and sell it today you would lose (3.00) from holding Processa Pharmaceuticals or give up 12.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  ACRO Biomedical Co

Processa Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in September 2025.

ACRO Biomedical

Risk-Adjusted Performance

Weakest

Over the last 90 days ACRO Biomedical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Processa Pharmaceuticals and ACRO Biomedical

The main advantage of trading using opposite Processa Pharmaceuticals and ACRO Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, ACRO Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACRO Biomedical will offset losses from the drop in ACRO Biomedical's long position.

The idea behind Processa Pharmaceuticals and ACRO Biomedical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.